Patents by Inventor Heinrich SCHLUMS

Heinrich SCHLUMS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NK CELLS EXHIBITING AN ADAPTIVE PHENOTYPE AND METHODS FOR PREPARING AND FOR USING
    Publication number: 20240360413
    Abstract: This disclosure describes an adaptive NK cell, an isolated population of adaptive Natural Killer (NK) cells, a composition including an adaptive NK cell, and methods for producing, preparing, and using an adaptive NK cell or an isolated population or composition including an adaptive NK cell. The adaptive NK cells may be used to treat a viral infection or a tumor.
    Type: Application
    Filed: June 26, 2024
    Publication date: October 31, 2024
    Inventors: Jeffrey MILLER, Frank CICHOCKI, Yenan BRYCESON, Heinrich SCHLUMS
  • NK cells exhibiting an adaptive phenotype and methods for preparing and for using
    Patent number: 12054744
    Abstract: This disclosure describes an adaptive NK cell, an isolated population of adaptive Natural Killer (NK) cells, a composition including an adaptive NK cell, and methods for producing, preparing, and using an adaptive NK cell or an isolated population or composition including an adaptive NK cell. The adaptive NK cells may be used to treat a viral infection or a tumor.
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: August 6, 2024
    Assignee: Regents of the University of Minnesota
    Inventors: Jeffrey Miller, Frank Cichocki, Yenan Bryceson, Heinrich Schlums
  • NK CELLS EXHIBITING AN ADAPTIVE PHENOTYPE AND METHODS FOR PREPARING AND FOR USING
    Publication number: 20210309969
    Abstract: This disclosure describes an adaptive NK cell, an isolated population of adaptive Natural Killer (NK) cells, a composition including an adaptive NK cell, and methods for producing, preparing, and using an adaptive NK cell or an isolated population or composition including an adaptive NK cell. The adaptive NK cells may be used to treat a viral infection or a tumor.
    Type: Application
    Filed: April 7, 2021
    Publication date: October 7, 2021
    Inventors: Jeffrey MILLER, Frank CICHOCKI, Yenan BRYCESON, Heinrich SCHLUMS
  • NK cells exhibiting an adaptive phenotype and methods for preparing and for using
    Patent number: 10995317
    Abstract: This disclosure describes an adaptive NK cell, an isolated population of adaptive Natural Killer (NK) cells, a composition including an adaptive NK cell, and methods for producing, preparing, and using an adaptive NK cell or an isolated population or composition including an adaptive NK cell. The adaptive NK cells may be used to treat a viral infection or a tumor.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: May 4, 2021
    Assignee: Regents of the University of Minnesota
    Inventors: Jeffrey Miller, Frank Cichocki, Yenan Bryceson, Heinrich Schlums
  • NK CELLS EXHIBITING AN ADAPTIVE PHENOTYPE AND METHODS FOR PREPARING AND FOR USING
    Publication number: 20180258396
    Abstract: This disclosure describes an adaptive NK cell, an isolated population of adaptive Natural Killer (NK) cells, a composition including an adaptive NK cell, and methods for producing, preparing, and using an adaptive NK cell or an isolated population or composition including an adaptive NK cell. The adaptive NK cells may be used to treat a viral infection or a tumor.
    Type: Application
    Filed: September 14, 2016
    Publication date: September 13, 2018
    Inventors: Jeffrey MILLER, Frank CICHOCKI, Yenan BRYCESON, Heinrich SCHLUMS